The selective 5-HT6 receptor antagonist SB-399885 enhances anti-immobility action of antidepressants in rats

European Journal of Pharmacology

Volumn 582, Issue 1-3, 2008, Pages 88-93

  Wesołowska, Anna ^a   Nikiforuk, Agnieszka ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

(Rat); 5 HT6 receptor antagonist; Antidepressants; Forced swim test; SB 399885

Indexed keywords

AMFEBUTAMONE; CITALOPRAM; DESIPRAMINE; IMIPRAMINE; MOCLOBEMIDE; N [3,5 DICHLORO 2 (METHOXY)PHENYL] 4 (METHOXY) 3 (1 PIPERAZINYL)BENZENE SULFONAMIDE; SB 399885; SEROTONIN 6 ANTAGONIST; SEROTONIN 6 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFECT; FORCED SWIMMING TEST; IMMOBILIZATION; LOCOMOTION; MALE; NONHUMAN; OPEN FIELD TEST; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RAT; TREATMENT RESPONSE;

ADRENERGIC UPTAKE INHIBITORS; ANIMALS; ANTIDEPRESSIVE AGENTS; BUPROPION; CITALOPRAM; DOPAMINE UPTAKE INHIBITORS; DRUG SYNERGISM; IMIPRAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MOCLOBEMIDE; MONOAMINE OXIDASE INHIBITORS; MOTOR ACTIVITY; PIPERAZINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; SEROTONIN ANTAGONISTS; SEROTONIN UPTAKE INHIBITORS; SULFONAMIDES;

EID: 39149091707     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2007.12.013     Document Type: Article

References (55)

1. Ago Y., Harasawa T., Itoh S., Nakamura S., Baba A., and Matsuda T. Antidepressant-like effect of coadministration of sulpiride and fluvoxamine in mice. Eur. J. Pharmacol. 520 (2005) 86-90
2. Artigas F., Adell A., and Celada P. Pindolol augmentation of antidepressant response. Curr Drug Targets 7 (2006) 139-147
3. Artigas F., Perez V., and Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch. Gen. Psychiatry 51 (1994) 248-251
4. 7A receptor. J. Biol. Chem. 273 (1998) 17469-17476
5. Blier P., and Bergeron R. Effectiveness of pindolol with selected antidepressant drugs in the treatment of major depression. J. Clin. Psychopharmacol. 15 (1995) 217-222
6. 1A receptors induces rapid antidepressant response. Neuropsychopharmacology 16 (1997) 333-338
7. 6 receptors stably expressed in HEK293 cells. Neuropharmacology 36 (1997) 713-720
8. 3H]Ro 63-0563 labels 5-hydroxytryptamine receptor binding sites in rat and porcine striatum. Mol. Pharmacol. 54 (1998) 577-583
9. Borsini F. Role of the serotonergic system in the forced swimming test. Neurosci. Biobehav. Rev. 19 (1995) 377-395
10. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. A review. Psychopharmacology 94 (1988) 147-160
11. 2-Adrenoceptor blockade prevents the effect of desipramine in the forced swimming test. Eur. J. Pharmacol. 175 (1990) 301-307
12. Cervo L., Grignaschi G., Rossi C., and Samanin R. Role of central serotonergic neurons in the effect of sertraline in rats in the forced swimming test. Eur. J. Pharmacol. 196 (1991) 217-222
13. Da-Rocha M.A., Puech A.J., and Thiebot M.-H. Influence of anxiolytic drugs on the effects of specific serotonin reuptake inhibitors in the forced swimming test in mice. J. Psychopharmacol. 11 (1997) 211-218
14. 6 receptor blockade on the neurochemical outcome of antidepressant treatment in the frontal cortex of the rat. J. Neural. Transm. 110 (2003) 577-590
15. Dawson L.A., Nguyen H.Q., and Li P. The 5-HT6 receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus. Neuropsychopharmacology 25 (2001) 662-668
16. 6 receptor antagonist. Brain Res. Bull. 59 (2003) 513-521
17. Frantz K.J., Hansson K.J., Stouffer D.G., and Parsons L.H. 5-HT6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine. Neuropharmacology 42 (2002) 170-180
18. Gerard C., Martres M.P., Lefevre K., Miquel M.C., Verge D., Lanfumey L., Doucet E., Hamon M., and el Mestikawy S. Immuno-localization of serotonin 5-HT6 receptor-like material in the rat central nervous system. Brain Res. 746 (1997) 207-219
19. 6 receptor mRNA in the central nervous system of control or 5,7-dihydroxytryptamine-treated rats. Synapse 23 (1996) 164-173
20. 6 receptor antagonist with cognitive enhancing properties in aged rat water maze and novel object recognition models. Eur. J. Pharmacol. 553 (2006) 109-119
21. Janssen P.A.J., Jagenau A.H.M., and Schellekens K.H.C. Chemistry and pharmacology of compound related to 4-(4-hydroxy-4-phenylpiperidino)-butyrophenone. IV: influence of haloperidol (R-1625) and chloropromazine on the behaviour of rats in an unfamiliar open field situation. Psychopharmacologia 1 (1960) 389-392
22. 6 serotonin receptor and mutagenesis studies of the third cytoplasmic loop. Brain Res. Mol. Brain Res. 90 (2001) 110-117
23. 6 serotonin receptor. J. Neurochem. 66 (1996) 47-56
24. Lacroix L.P., Dawson L.A., Hagan J.J., and Heidbreder C.A. 5-HT6 receptor antagonist SB-271046 enhances extracellular levels of monoamines in the rat medial prefrontal cortex. Synapse 51 (2004) 158-164
25. 6 receptor antagonist SB-399885 potentiates haloperidol and risperidone-induced dopamine efflux in the medial prefrontal cortex or hippocampus. Brain Res. 1134 (2007) 70-78
26. 2A receptor antagonist M100907 enhances antidepressant-like behavioral effects of the SSRI fluoxetine. Neuropsychopharmacology 30 (2005) 2205-2215
27. 1B receptor mutant mice. J. Pharmacol. Exp. Ther. 298 (2001) 1101-1107
28. Millan M.J. Multi-target strategies for the improved treatment of depressive states: conceptual foundations and neuronal substrates, drug discovery and therapeutic application. Pharmacol. Ther. 110 (2006) 135-370
29. Millan M.J., Brocco M., Veiga S., Cistarelli L., Melon C., and Gobert A. WAY 100,635 enhances both the 'antidepressant' actions of duloxetine and its influence on dialysate levels of serotonin in frontal cortex. Eur. J. Pharmacol. 341 (1998) 165-167
30. 2A receptors suppresses the induction of locomotor activity by 5-HT reuptake inhibitors, citalopram and fluvoxamine, in NMRI mice exposed to a novel environment: a comparison to other 5-HT receptor subtypes. Psychopharmacology 168 (2003) 397-409
31. Monsma F.J., Shen Y., Ward R.P., Hamblin M.W., and Sibley D.R. Cloning and expression of a novel serotonin receptor with high affinity for tricyclic psychotropic drugs. Mol. Pharmacol. 43 (1993) 320-327
32. 1A receptor antagonists neither potentiate nor inhibit the effects of fluoxetine and befloxatone in the forced swim test in rats. Eur. J. Pharmacol. 372 (1999) 127-134
33. O'Neill M.F., Fernandez A.G., and Palacios J.M. GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test. Pharmacol. Biochem. Behav. 53 (1996) 535-539
34. Papp M., Nalepa I., Antkiewicz-Michaluk L., and Sanchez C. Behavioural and biochemical studies of citalopram and WAY 100635 in rat chronic mild stress model. Pharmacol. Biochem. Behav. 72 (2002) 465-474
35. Perez V., Gilaberte I., Faries D., Alvarez E., and Artigas F. Randomised, double-blind, placebo-controlled trial of pindolol in combination with fluoxetine antidepressant treatment. Lancet 349 (1997) 1594-1597
36. Plassat J.L., Amlaiky N., and Hen R. Molecular cloning of a mammalian serotonin receptor that activates adenylate cyclase. Mol. Pharmacol. 44 (1993) 229-236
37. Porsolt R.D., Anton G., Blavet N., and Jalfre M. Behavioural despair in rats: a new model sensitive to antidepressant treatments. Eur. J. Pharmacol. 47 (1978) 379-391
38. Porsolt R.D., Bertin A., Blavet N., Deniel M., and Jalfre M. Immobility induced by forced swimming in rats: effects of agents which modify central catecholamine and serotonin activity. Eur. J. Pharmacol. 57 (1979) 201-210
39. 6 antagonist MS-245. Pharmacol. Biochem. Behav. 78 (2004) 263-268
40. 3 receptors in the activity of antidepressants in the mouse forced swimming test. Eur. J. Pharmacol. 325 (1997) 129-135
41. 1B receptors in antidepressant drug actions in the mouse forced swimming test. Eur. J. Pharmacol. 318 (1996) 213-220
42. Reneric J.P., Bouvard M., and Stinus L. Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA, or 5-HT, or dual NA/5-HT reuptake inhibition in the forced swimming test. Neuropsychopharmacology 24 (2001) 379-390
43. Ruat M., Traiffort E., Arrang J.M., Tardivel-Lacombe J., Diaz J., Leurs R., and Schwartz J.C. A novel rat serotonin (5-HT6) receptor: molecular cloning, localization and stimulation of cAMP accumulation. Biochem. Biophys. Res. Commun. 193 (1993) 68-76
44. Sacristan J.A., Gilaberte I., Boto B., Buesching D.P., Obenchain R.L., Demitrack M., Sola V.P., Alvarez E., and Artigas F. Cost-effectiveness of fluoxetine plus pindolol in patients with major depressive disorder: results from a randomized, double-blind clinical trial. Int. Clin. Psychopharmacol. 15 (2000) 107-113
45. 6 receptors positively coupled to adenylyl cyclase in striatal neurones in culture. Neuro Report 5 (1994) 2553-2557
46. 6 receptor stimulation. J. Neurosci. 27 (2007) 4201-4209
47. 1B receptor antagonists and paroxetine or fluoxetine in the forced swimming test in rats. Pol. J. Pharmacol. 54 (2002) 615-623
48. 1B/1D receptor antagonists and antidepressants in the forced swimming test. Eur. J. Pharmacol. 487 (2004) 133-142
49. Thase M.E., and Rush A.J. Treatment-resistant depression. In: Bloom F.E., and Kupfer D.J. (Eds). Psychopharmacology: The Fourth Generation of Progress (1995), Raven Press, New York 1081-1097
50. Tome M.B., Isaac M.T., Harte R., and Holland C. Paroxetine and pindolol: a randomized trial of serotonergic autoreceptor blockade in the reduction of antidepressant latency. Int. Clin. Psychopharmacol. 12 (1997) 81-89
51. Ward R.P., Hamblin M.W., Lachowicz J.E., Hoffman B.J., Sibley D.R., and Dorsa D.M. Localization of serotonin subtype 6 receptor messenger RNA in the rat brain by in situ hybridization histochemistry. Neuroscience 64 (1995) 1105-1111
52. 6 receptor antagonist SB-399885 in animal models of anxiety and depression. Neuropharmacology 52 (2007) 1274-1283
53. 6 receptor antagonist SB-258585 after its intrahippocampal administration to rats. Behav. Pharmacol. 18 (2007) 439-446
54. 7 receptor antagonist in the forced swimming test in mice. Eur. J. Pharmacol. 555 (2007) 43-47
55. 6 receptor subtype in the rat brain. Life Sci. 62 (1998) 1473-1477